Skip to main content
Lepu Biopharma Co., Ltd. logo

Lepu Biopharma Co., Ltd. — Investor Relations & Filings

Ticker · 2157 ISIN · CNE100004SM4 HKEX Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2023-08-09 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 2157

About Lepu Biopharma Co., Ltd.

http://www.lepubiopharma.com

Lepu Biopharma Co., Ltd. is an innovation-driven biopharmaceutical company dedicated exclusively to the research and development of oncology therapeutics. The company focuses on advanced tumor treatment modalities, including targeted therapy and cancer immunotherapy. Its strategically built product pipeline encompasses a range of candidate drugs, notably Antibody-Drug Conjugates (ADCs), immunotherapies, and oncolytic virus drugs, with assets spanning clinical and preclinical development stages. Lepu Biopharma leverages its proprietary ADC technology platform to drive the development of innovative treatments. The company pursues domestic commercialization through dedicated sales infrastructure while actively seeking global market access, particularly in the US and European markets, via strategic partnerships and out-licensing agreements for its drug candidates.

Recent filings

Filing Released Lang Actions
PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTIONS CONCERNING THE PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD, PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTION AU
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Lepu Biopharma Co., Ltd. regarding the proposed extension of the validity period of resolutions related to the proposed issue of A shares and listing on the Sci-Tech Board, and it includes a notice of an Extraordinary General Meeting (EGM). It contains detailed information about the resolutions, the board's letter, definitions, and proxy forms for the EGM. The document is not a full financial report, earnings release, or audit report. It is a formal communication to shareholders providing information and requesting votes on specific corporate actions. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2023-08-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 July 2023. It details movements in authorised/registered share capital, issued shares, and confirms compliance with listing rules. The content is regulatory in nature, reporting share capital and share movements to the Hong Kong Exchanges and Clearing Limited. It does not contain financial statements, earnings data, or management discussion. It is a regulatory compliance filing related to share capital movements and confirmations, fitting the category of Regulatory Filings (RNS). The document length (7359 characters) and detailed content confirm it is not a brief announcement but a regulatory return. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-08-04 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 100% confidence The document is titled 'Articles of Association' and contains detailed chapters and articles about the company's organizational structure, share issuance, board of directors, management, financial accounting system, and other governance-related provisions. It references the company's incorporation, regulatory approvals, share structure, and internal rules. There is no indication that this is a financial report, earnings release, or meeting presentation. Instead, it is a governance document outlining the company's internal rules and governance practices. Therefore, the document best fits the category of Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full Articles of Association, not just an announcement or summary.
2023-08-01 English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Board/Management Information Classification · 90% confidence The document is a voluntary announcement by Lepu Biopharma Co., Ltd. regarding the proposed amendments to the Articles of Association. It references prior notices, circulars, and announcements related to shareholder meetings and voting results. The document states that the amendments have taken effect following regulatory changes. The content focuses on corporate governance changes, specifically amendments to the Articles of Association, which is a governance matter. The document is relatively short (3018 characters) and serves as an announcement rather than a full report. It does not contain financial statements or detailed financial data. Therefore, it fits best under Board/Management Information (MANG) as it relates to changes in company governance documents and board-related announcements rather than a full governance report or regulatory filing.
2023-08-01 English
PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTIONS CONCERNING THE ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS AND CLOSURE OF REGISTER OF MEMBERS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Lepu Biopharma Co., Ltd. regarding the proposed extension of the validity period of previously approved resolutions related to the issue of A shares and listing on the Sci-Tech Board. It references prior circulars and meetings, and announces the scheduling of new extraordinary general meetings and class meetings to approve the extension. The document does not contain financial statements or detailed financial data, but rather is a formal announcement about corporate governance matters and shareholder meeting arrangements. It also includes information about the closure of the register of members for voting purposes. This type of document is an official announcement related to capital raising and listing activities, specifically about extending the validity of shareholder resolutions concerning share issuance and listing. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8850 characters) and content confirm it is not a brief report publication announcement or a regulatory filing fallback. Confidence is high given the clear focus on share issuance resolutions and listing preparations.
2023-07-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings Classification · 100% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 June 2023. It details movements in authorised/registered share capital, issued shares, and confirms compliance with listing rules. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements for a specific month. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report publication but a regulatory filing of share capital movements. Therefore, it fits best under Regulatory Filings (RNS).
2023-07-03 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.